Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4797266
Max Phase: Preclinical
Molecular Formula: C57H75N15O9
Molecular Weight: 1114.32
Molecule Type: Unknown
Associated Items:
ID: ALA4797266
Max Phase: Preclinical
Molecular Formula: C57H75N15O9
Molecular Weight: 1114.32
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O
Standard InChI: InChI=1S/C57H75N15O9/c1-33(73)66-44(25-34-12-3-2-4-13-34)52(77)72-48-29-49(74)62-22-10-9-18-42(50(58)75)67-54(79)46(27-38-30-64-41-17-8-7-16-40(38)41)70-51(76)43(19-11-23-63-57(59)60)68-53(78)45(26-35-20-21-36-14-5-6-15-37(36)24-35)69-55(80)47(71-56(48)81)28-39-31-61-32-65-39/h5-8,14-17,20-21,24,30-32,34,42-48,64H,2-4,9-13,18-19,22-23,25-29H2,1H3,(H2,58,75)(H,61,65)(H,62,74)(H,66,73)(H,67,79)(H,68,78)(H,69,80)(H,70,76)(H,71,81)(H,72,77)(H4,59,60,63)/t42-,43-,44-,45+,46-,47-,48-/m0/s1
Standard InChI Key: NMXSKMOZDYUBHU-JLQGYNGPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1114.32 | Molecular Weight (Monoisotopic): 1113.5872 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Martin C,Gimenez LE,Williams SY,Jing Y,Wu Y,Hollanders C,Van der Poorten O,Gonzalez S,Van Holsbeeck K,Previti S,Lamouroux A,Zhao S,Tourwé D,Stevens RC,Cone RD,Ballet S. (2021) Structure-Based Design of Melanocortin 4 Receptor Ligands Based on the SHU-9119-hMC4R Cocrystal Structure†., 64 (1.0): [PMID:33190475] [10.1021/acs.jmedchem.0c01620] |
Source(1):